CNS, Medulloblastoma
Oncology·MeSH: Medulloblastoma
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target CNS, Medulloblastoma?
There are 1 clinical trial targeting CNS, Medulloblastoma tracked by BioSniper.
What is the prevalence of CNS, Medulloblastoma?
The estimated prevalence of CNS, Medulloblastoma is approximately 5.0 per 100,000 population.
Deep-dive into CNS, Medulloblastoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis